Nanoliposomal VEGF-R2 peptide vaccine acts as an effective therapeutic vaccine in a murine B16F10 model of melanoma

Abstract Background The vascular endothelial growth factor receptor-2 (VEGFR-2) plays an important role in melanoma development and progression. Peptide vaccines have shown great potential in cancer immunotherapy by targeting VEGFR-2 as a tumor-associated antigen and boosting the immune response aga...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Fatemeh Zahedipour, Parvin Zamani, Mohammad Mashreghi, Mojgan Astaneh, Mojtaba Sankian, Atefeh Amiri, Khadijeh Jamialahmadi, Mahmoud Reza Jaafari
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2023-06-01
Serie:	Cancer Nanotechnology
Soggetti:	Nanoliposomal vaccine VEGFR-2 Peptide vaccine Melanoma
Accesso online:	https://doi.org/10.1186/s12645-023-00213-7
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!